A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine

Launched by BOTANEE GROUP CO., LTD. · Mar 18, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether using a special anti-aging serum for 14 days before undergoing a specific laser treatment can help reduce skin discomfort. The treatment in question is the Fotona 4D laser therapy, which is often used to improve skin appearance and treat signs of aging like fine lines and rough skin. The study will compare how the skin looks and feels after using the serum versus a control product.

To participate, women aged 35 to 60 who have some signs of skin aging, such as roughness or fine lines, may be eligible. Participants should not have any history of allergies to cosmetic products and must be willing to use the test serum on one half of their face while receiving the laser treatment on both sides. It’s important to note that pregnant or nursing women, or those with certain skin conditions, won’t be able to take part. Throughout the study, participants can expect to follow a skincare routine and provide feedback on their experience. Overall, this trial aims to find out if the serum can make the laser treatment more comfortable and effective.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • health females aged 35-60;
• • subjects with rough dark, loose fine lines;
• • no history of cosmetic allergies;
• • subjects are willing to use the test serum on split-face for 28 days;
• • subjects are willing to suffer the Fotona 4D treatment (Frac3 and Piano modes) on the face;
• • subjects are willing to use the basic skincare products for 28 days, and acceptable for split-face use of the test products or the control product for 14 days;
• • written informed consent and portrait right consent were obtained from all participants before study entry.
• Exclusion Criteria:
• • anyone who is pregnant, nursing an infant, or planning a pregnancy during the study;
• • subjects with known allergies or sensitivities to the ingredients in any of the study products;
• • any symptoms of facial flushing, erythema, papules, desquamation, or edema as evaluated by a physician prior to initial screening or Fotona4D Pro treatment;
• • unhealed skin lesions;
• • participated in any other clinical trial within one month;
• • received facial skin treatments including but not limited to lasers, chemical peels, and dermal fillers within one month;
• • taken/injected anti-allergy medication in the past one month;
• • participants in other clinical trials at the same time;
• • any subjects that the investigator considers ineligible.